Showing results (4901-4910 of 5,051) with videos related to

Sort By:
Pageof 506
Headache|November 14, 2025
No differences in subcortical volume between people with and without migraine: A REFORM studyBasit Ali Chaudhry, Rune Häckert Christensen, Håkan Ashina, et al.
Headache|November 17, 2025
Effect of GLP-1 receptor agonists on idiopathic intracranial hypertension: A systematic reviewHelen Michaela de Oliveira, Mariano Gallo Ruelas, Pandora Eloa Oliveira Fonseca, et al.
Headache|December 29, 2025
Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trialEmmanuelle A D Schindler, Christopher H Gottschalk, Brian P Pittman, et al.
Headache|December 29, 2025
Migraine prevalence and phenotype in autism: A retrospective cohort study using a US National Health Survey and large academic health system electronic health recordMaria Pia Grant Tejada, Alexandra M Klomhaus, Rebecca Ortiz, et al.
Headache|January 21, 2026
Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi-source dataset, observational cohort studyDawn C Buse, Lindsay A Videnieks, Karissa Charles, et al.
Headache|December 31, 2025
Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham-controlled studyNan Cheng, Christopher C Anderson, Nan Zhang, et al.
Headache|January 7, 2026
Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) studyJessica Ailani, Rose Okonkwo, Elizabeth Johnston, et al.
Headache|November 4, 2025
Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine studyJessica Ailani, Larry Charleston, Shannon Strom, et al.
Headache|October 14, 2025
Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real-life multicenter studyJulia Peris-Subiza, Víctor Obach, Daniel Guisado-Alonso, et al.
Headache|October 4, 2025
Can atogepant be a preventive treatment for cluster headache?-Insights from a case seriesCatarina Serrão, Filipa Dourado Sotero, Linda Azevedo Kaupilla, et al.
Pageof 506